Former New York mayor Ed Koch dies at 88

Former New York Mayor, the brash and outspoken Ed Koch, has passed away at the age of 88.










NEW YORK (Reuters) - Former Mayor Edward Koch, who presided over New York City during the turbulent late 1970s and '80s and came to personify the city with his wry and outspoken style, died on Friday at the age of 88, his spokesman said.

As mayor from 1978 to 1989, the forceful, quick-witted Koch, with his trademark phrase "How'm I Doing?," was a polarizing figure and the city's constant promoter.






Koch died of congestive heart failure at about 2 a.m. at New York-Presbyterian hospital after a year of repeated hospitalizations, the spokesman for Koch said.

Koch was credited with lifting New York from crushing economic crises to a level of prosperity that was the envy of other U.S. cities. Under his leadership, the city regained its fiscal footing and undertook a building renaissance.

But his three terms in office were also marked by racial tensions, corruption among many of his political cronies, the rise in AIDS and HIV, homelessness and a high crime rate. In 1989, he lost the Democratic nomination for what would have been a record fourth term as mayor.

Mayor Michael Bloomberg said the flags at all city buildings would fly at half-staff in Koch's memory.

"In elected office and as a private citizen, he was our most tireless, fearless, and guileless civic crusader," Bloomberg said. "His spirit will live on not only here at City Hall, and not only on the bridge the bears his name, but all across the five boroughs."

Koch had a quip for every occasion and once said he wanted to be mayor for life. He was the only U.S. mayor to have a bestselling autobiography that was turned into an off-Broadway musical.

This week, "Koch," a documentary about his turbulent three terms as mayor, premiered at the Museum of Modern Art. Koch was unable to attend the premier.

"I don't think there was anybody who had more fun being mayor as Ed Koch," City Council Speaker Christine Quinn, who is in the race to be the city's next mayor, said at the premier.

"Here was a mayor who was a combination of a Lindy's waiter, a Coney Island barker, a Catskill comedian, an irritated school principal and an eccentric uncle," New York writer Pete Hamill said in a 2005 discussion of Koch's legacy. "He talked tough and the reason was, he was tough."

NEW YORK NATIVE

Born into a Jewish immigrant family in the Bronx on December 12, 1924, Edward Irving Koch went on to attend City College and later earn a law degree from New York University.

He entered politics in the 1950s in Manhattan's Greenwich Village neighborhood, winning a seat on the city council, and later went to Washington, where he served four terms in the U.S. House of Representatives.

In 1977, he made a second attempt running for mayor of New York City, and proved to be an agile campaigner. To combat rumors he was gay, former beauty queen Bess Myerson began appearing by his side at campaign events.

Koch later admitted the two were never romantically linked. Koch remained a bachelor all his life and refused to answer questions about his sexuality even in his later years.

After two successful terms in office - he was returned for a third term with 70 percent of the vote - Koch's star had began to fade. A corruption scandal involving his ally, Queens Borough President Donald Manes, never implicated Koch, but it damaged his reputation with voters.

Koch's attempt at a fourth term failed when he lost his party's nomination to Manhattan borough president David Dinkins, a man as quiet and deliberative as Koch was bold and abrasive. Dinkins would go on to be the city's first black mayor.

"People became tired of Koch's personality," said Mitchell Moss, the director of the Urban Research Center at New York University. "He was a remarkable mayor but one with a big mouth. After 12 years you have to change the lyrics."

After leaving office, Koch wrote articles on everything from Middle East politics to movie reviews, hosted a radio show and served as a judge on television's "“The People's Court."

He has remained a formidable figure in New York politics, endorsing candidates and offering political commentary on the local NY1 TV station. He has been a strong ally of New York's current mayor, Michael Bloomberg, and in 2010 he formed New York Uprising, a political action committee designed to fight corruption in state politics.

In 2008, Koch announced he had secured a plot in Manhattan's Trinity Cemetery, telling the New York Times: "The idea of leaving Manhattan permanently irritates me."

(Additional reporting by David Storey, Editing by Colleen Jenkins and W Simon)

Read More..

Mexico rescue workers search for survivors after Pemex blast kills 25


MEXICO CITY (Reuters) - Emergency services worked into the early hours of Friday to find people trapped in rubble under state oil company Pemex's headquarters in Mexico City after an explosion that killed at least 25 people and injured more than 100.


Scenes of confusion and chaos at the downtown tower dealt yet another blow to Pemex's image as Mexico's new president courts outside investment for the 75-year-old monopoly.


Search and rescue workers picked through debris, and investigators sifted through shattered glass and concrete at the bottom of the building to try to find what caused the blast. It was not clear how many might still be trapped inside.


Pemex, a symbol of Mexican self-sufficiency as well as a byword in Mexico for security glitches, oil theft and frequent accidents, has been hamstrung by inefficiency, union corruption and a series of safety failures costing hundreds of lives.


Thursday's blast at the more than 50-storey skyscraper that houses administrative offices followed a September fire at a Pemex gas facility near the northern city of Reynosa which killed 30 people. More than 300 were killed when a Pemex natural gas plant on the outskirts of Mexico City blew up in 1984.


Eight years later, about 200 people were killed and 1,500 injured after a series of underground gas explosions in Guadalajara, Mexico's second biggest city. An official investigation found Pemex was partly to blame.


Pemex initially flagged Thursday's incident as a problem with its electricity supply and then said there had been an explosion. But it did not give a cause for the blast.


A government official, speaking on condition of anonymity, said a preliminary line of inquiry suggested a gas boiler had blown up in a Pemex building just to the side of the main tower. However, he stressed nothing had been determined for sure.


Others at the scene said gas may have caused the blast.


Not long after the blast, President Enrique Pena Nieto was at the scene, vowing to discover how it happened.


"We will work exhaustively to investigate exactly what took place, and if there are people responsible, to apply the force of the law on them," he told reporters before going to visit survivors in hospital.


Shortly after midnight, at least 46 victims were still being treated in hospital, the company said.


Pemex said the blast would not affect operations, but concern in the government was evident as top military officials, the attorney general and the energy minister joined Interior Minister Miguel Angel Osorio Chong for a late news conference.


"I have issued instructions to the relevant authorities to convene national and international experts to help in the investigations," Osorio Chong said. He later noted that the number of casualties could still climb.


Whatever caused it, the deaths and destruction will put the spotlight back on safety at Pemex, which only a couple of hours before the explosion had issued a statement on Twitter saying the company had managed to improve its record on accidents.


Nieto has said he is giving top priority to reforming the company this year, though he has yet to reveal details of the plan, which already faces opposition from the left.


Both Pena Nieto and his finance minister were this week at pains to stress the company will not be privatized.


(Editing by Louise Ireland)



Read More..

Stock futures edge lower ahead of data, earnings

NEW YORK (Reuters) - Stock index futures edged lower on Thursday ahead of data on the labor market and a slew of corporate earnings reports.


Facebook Inc shares dropped 6.7 percent to $29.14 in premarket trading. The company doubled its mobile advertising revenue in the fourth quarter but that growth trailed some of Wall Street's most aggressive estimates.


Qualcomm Inc gained 6 percent to $67.35 in premarket trading after the world's leading supplier of chips for cellphones beat analysts' expectations for quarterly profit and revenue and raised its financial targets for 2013.


Investors will look to weekly initial jobless claims data at 8:30 a.m. ET (1330 GMT) for clues on the health of the labor market ahead of the payrolls report on Friday. Economists in a Reuters survey forecast a total of 350,000 new filings compared with 330,000 in the prior week.


Also at 8:30 a.m. (1330 GMT), the Commerce Department will release December personal income and spending data; economists expect a 0.8 percent rise in income and a 0.3 percent increase in spending.


ConocoPhillips reported a drop in quarterly profit as oil and gas prices weakened and output from the third-largest U.S. oil and gas producer remained steady compared with a year ago, though it anticipated a decline in the first quarter.


Later in the session at 9:45 a.m. (1445 GMT), the Institute for Supply Management Chicago releases January index of manufacturing activity. Economists in a Reuters survey forecast a reading of 50.5 compared with 50.0 in December.


S&P 500 futures fell 1.4 points and were below fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures rose 5 points, and Nasdaq 100 futures lost 9.75 points.


The S&P 500 <.spx> is up 5.3 percent for the month, as legislators in Washington temporarily sidestepped a "fiscal cliff" of automatic tax increases and spending cuts that could have derailed the economic recovery, and amid improving economic data and better-than-expected corporate earnings.


But the benchmark index has stalled recently, hovering near the 1,500 mark over the past four sessions as investors look for more catalysts to justify further gains.


Thomson Reuters data through Wednesday morning shows that of the 192 companies in the S&P 500 that have reported earnings this season, 68.8 percent have exceeded expectations, a higher proportion than over the past four quarters and above the average since 1994.


Overall, S&P 500 fourth-quarter earnings are forecast to have risen 3.8 percent. That's above the 1.9 percent forecast from the start of the earnings season, but well below a 9.9 percent fourth-quarter earnings growth forecast on October 1, the data showed.


European shares fell as investors digested mixed earnings reports, with a warning from AstraZeneca knocking its shares while Ericsson surged after fourth-quarter results. <.eu/>


Asian shares fell slightly after rallying to multi-month highs, and more for some Southeast Asian markets, while the U.S. Federal Reserve's pledge to retain its stimulus policy undermined the dollar.


(Editing by Bernadette Baum)



Read More..

2 NFL seasons since agreement, still no HGH tests


NEW ORLEANS (AP) — Count Baltimore Ravens defensive end Arthur Jones among those NFL players who want the league and the union to finally agree on a way to do blood testing for human growth hormone.


"I hope guys wouldn't be cheating. That's why you do all this extra work and extra training. Unfortunately, there are probably a few guys, a handful maybe, that are on it. It's unfortunate. It takes away from the sport," Jones said.


"It would be fair to do blood testing," Jones added. "Hopefully they figure it out."


When Jones and the Ravens face the San Francisco 49ers in the Super Bowl on Sunday, two complete seasons will have come and gone without a single HGH test being administered, even though the league and the NFL Players Association paved the way for it in the 10-year collective bargaining agreement they signed in August 2011.


Since then, the sides have haggled over various elements, primarily the union's insistence that it needs more information about the validity of a test that is used by Olympic sports and Major League Baseball. HGH is a banned performance-enhancing drug that is hard to detect and has been linked to health problems such as diabetes, cardiac dysfunction and arthritis.


"If there are guys using (HGH), there definitely needs to be action taken against it, and it needs to be out of (the sport)," Ravens backup quarterback Tyrod Taylor said. "I'm pretty sure it'll happen eventually."


At least two members of Congress want to make it happen sooner, rather than later.


House Oversight and Government Reform Committee chairman Darrell Issa, a California Republican, and ranking Democrat Elijah Cummings of Maryland wrote NFLPA head DeMaurice Smith this week to chastise the union for standing in the way of HGH testing and to warn that they might ask players to testify on Capitol Hill.


Smith is scheduled to hold his annual pre-Super Bowl news conference Thursday.


"We have cooperated and been helpful to the committee on all of their requests," NFLPA spokesman George Atallah said. "If this is something they feel strongly about, we will be happy to help them facilitate it."


Several players from the Super Bowl teams said they would be willing to talk to Congress about the issue, if asked.


"I have nothing to hide. I can't speak for anyone else in football, but I would have no problem going," said Kenny Wiggins, a 6-foot-6, 314-pound offensive lineman on San Francisco's practice squad.


But Wiggins added: "There's a lot more problems in the U.S. they should be worried about than HGH in the NFL."


That sentiment was echoed by former New York Giants offensive lineman Shaun O'Hara, who now works for the NFL Network.


"Do I think there is an HGH problem in the NFL? I don't think there is. Are there guys who are using it? I'm sure there are. But is it something Congress needs to worry about? No. We have enough educated people on both sides that can fully handle this. And if they can't, then they should be fired," said O'Hara, an NFLPA representative as a player. "I include the union in that, and I include the NFL. There is no reason we would need someone to help us facilitate this process."


Issa and Cummings apparently disagree.


In December, their committee held a hearing at which medical experts testified that the current HGH test is reliable and that the union's request for a new study is unnecessary. Neither the league nor union was invited to participate in that hearing; at the time, Issa and Cummings said they expected additional hearings.


"We are disappointed with the NFLPA's remarkable recalcitrance, which has prevented meaningful progress on this issue," they wrote in their recent letter to Smith. "We intend to take a more active role to determine whether the position you have taken — that HGH is not a serious concern and that the test for HGH is unreliable — is consistent with the beliefs of rank and file NFL players."


Atallah questioned that premise.


"To us, there is no distinction between players and the union. ... The reason we had HGH in our CBA is precisely because our players wanted us to start testing for it," Atallah said. "We are not being recalcitrant for recalcitrance sake. We are merely following the direction of our player leadership."


Wiggins and other players said no one can know for sure how much HGH use there is in the league until there is testing — but that it's important for the union's concerns about the test to be answered.


"The union decides what is best for the players," said Ravens nose tackle Ma'ake Kemoeatu, who said he would be willing to go to Capitol Hill.


"I feel like some guys are on HGH," said 49ers offensive lineman Anthony Davis, who would rather not speak to Congress. "I personally don't care if there is testing. It's something they have to live with, knowing they cheated, and if they get (outplayed) while they're on it, it's a hit on their pride."


___


Follow Howard Fendrich on Twitter at http://twitter.com/HowardFendrich


Read More..

Factbox: Weapons, nuclear power, roads and welfare: India’s budget cuts






NEW DELHI (Reuters) – India’s finance minister P. Chidambaram is putting welfare, defence, atomic energy and road projects under the knife in a final attempt to hit a tough fiscal deficit target by March, risking short-term economic growth and angering cabinet colleagues.


The cuts will reduce spending by about 1.1 trillion Indian rupees ($ 20.6 billion) in the current financial year, some 8 percent of budgeted outlay, or roughly 1 percent of estimated gross domestic product, two senior finance ministry officials and a senior government adviser told Reuters.






Here are some of the details of the cuts so far and where the axe is falling:


* The defence ministry — the world’s biggest arms importer in recent years — faces a cut of $ 1.9 billion for weapons purchases, which a senior official said could delay deals to buy howitzer guns and Javelin anti-tank missiles from the United States by at least few months.


* The rural development ministry, which runs a flagship rural employment scheme that is seen as a major vote winner, could have up to $ 4 billion slashed from its budget, a senior official at the ministry said.


* Government data for the April-November period, for which spending numbers are available, show a fall in disbursements to ministries — and purse strings are tightening further in the traditionally high-spending last quarter of the fiscal year. A senior finance ministry official said ministries will not get more than a third of their allocated funds in the quarter to March.


* The atomic energy department was allocated only 13 billion rupees ($ 243.47 million) by November-end, out of 56 billion rupees ($ 1.05 billion) approved in the budget for the whole year, a finance ministry official said.


* Just 35.7 billion rupees ($ 668.60 million) were released to the ministry of communications and information technology in the same period out of 86 billion rupees ($ 1.61 billion) budgeted for the whole year, the official said.


* Overall in the April-November period, spending on more than 100 capital investment program stood at 2.43 trillion rupees ($ 45.51 billion), 47 percent of the target of 5.21 trillion rupees ($ 97.57 billion) for the whole fiscal year, compared with 50 percent a year earlier.


* The roads ministry has so far awarded contracts for just 1,000 km (620 miles) of roads against a target of 9,000 km this fiscal year, partly due to budget constraints and the deteriorating economy, an official at the ministry said. The ministry has been told to look for funds from the National Highway Authority, partly funded by market borrowing.


* One reason the cuts are needed is a rising subsidy bill. The finance ministry expects the burden for providing cheaper fuel to jump by nearly 500 billion Indian rupees ($ 9.36 billion) this year, above earlier estimates of 430 billion rupees ($ 8.05 billion).


* Another factor is low revenue collection – in the first eight months, collections were 47.6 percent of the annual target compared with 49.7 percent during the same period a year earlier, at a time Chidambaram is trying to substantially lower the deficit from last year’s 5.8 percent of GDP.


($ 1 = 53.3950 Indian rupees)


(Reporting By Frank Jack Daniel; Editing by Alex Richardson)


Energy News Headlines – Yahoo! News





Title Post: Factbox: Weapons, nuclear power, roads and welfare: India’s budget cuts
Url Post: http://www.news.fluser.com/factbox-weapons-nuclear-power-roads-and-welfare-indias-budget-cuts/
Link To Post : Factbox: Weapons, nuclear power, roads and welfare: India’s budget cuts
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

BlackBerry must remember strengths






STORY HIGHLIGHTS


  • BlackBerry sales have slumped in the U.S. but is still strong in emerging markets

  • New models launched should remember why they are popular in developing world

  • In places like Brazil and South Africa, the 10 is the update to their current phone

  • in Sub-Saharan Africa there is expected to be 175 million new customers in the next 3 years




Watch Jim Clancy on CNN International's "The Brief" at 4p.m. ET GMT Friday.


(CNN) -- BlackBerry's loss of market share in the U.S. is the stuff of legends. Last fall, it was estimated only about 2% of American phone users were still carrying their BlackBerry mobile with its iconic keypad.


But consider this: sub-Saharan Africa is expected to add 175 million new mobile users in just the coming 3 years. That's according to the GSMA, which represents the world's mobile operators.


"Mobile has already revolutionized African society and yet demand still continues to grow by almost 50 percent a year," said Tom Phillips, Chief Government and Regulatory Affairs Officer, GSMA.


That could be good news indeed for BlackBerry. Research in Motion, the maker of BlackBerry, estimates it holds a 70% market share in countries like South Africa.


The company's new phones, announced this week, are not the ones some of its best customers in emerging markets would like to buy. They're too expensive. But Research in Motion -- which also this week changed its company name to BlackBerry -- is pledging some of its six new models will address that.


While millions in China, Europe and the U.S. have adopted Android or iOS smartphones with a vengeance, millions more users in emerging markets are enthused about what's in store for the new BlackBerry 10. It's the update for what many of them are already using.










They live in countries like Brazil, Malaysia, Nigeria, Kenya and South Africa. They have embraced the BlackBerry for a combination of factors that all point to the different way mobile devices are used.


Unlike their counterparts in Europe and America, the mobile in their pocket is more likely to be their primary link to the internet.


BlackBerry Messenger is the connection that allows these users unlimited conversations without paying charges for SMS data. While young, brand-conscious Chinese may be willing to part with several months' salary to buy the latest iPhone, African users are looking for more practical (and cheaper) connections.


What separates developed countries from their developing counterparts at street level can be summed up in a single word: infrastructure.


Isobel Coleman, senior fellow and Director of the Civil Society, Markets and Democracy Initiative at the Council on Foreign Relations, says mobile technology has proved it can bridge the gap where infrastructure is lacking.


"It's a culture, it's an economy, it's innovation, education, healthcare, it's all of these things," says Coleman.


You can take that to the bank. For many Africans, their cell phone account is the first bank account they've ever owned.


In emerging markets, mobile phone banking is growing because of the lack of infrastructure. Fewer bank branches often mean long distances to travel and long lines once you've arrived.


Africans are expected to transfer more than $200 billion per year or 18% of the continent's GDP by 2015.


Oh, and that keyboard. No matter where you are in the world, there will always be a demand for a keyboard that clicks. The company appears to understand that as BlackBerry 10 models come with both soft keypads and the traditional BlackBerry buttons.


I asked some of my Twitter followers to weigh in on the BlackBerry 10 roll out. While some said Android or Apple's iOS were in their future plans, many others expressed continued enthusiasm for the BlackBerry.


Soji, a pianist and teacher in Nigeria tweeted back "I'm falling in love with this BB. Cheaper to own."


From Kuala Lumpur, Amir wrote "I need a physical keyboard to type while also having a touch-screen for photos etc. Security factor also important."


Hans-Eric from South Africa reinforced the sentiments of many mobile users in emerging markets: "The cost of data is simply too high without it (BlackBerry.)"


The voices from emerging markets couldn't have been clearer. What they expect from BlackBerry 10 is a stronger, longer lasting battery, durability and continued low cost connectivity.


CFR's Coleman agrees that BlackBerry (and anyone else) trying to win and hold this mobile device sector has to understand how these devices are being used and give the customers what they want.


"Cheap. Rugged. Not too many bells and whistles. Practical."


There is little doubt smartphones are changing the way people use the internet, how they bank, shop and interact socially.


But it's worth keeping in perspective that in a world where there are now an estimated 1 billion smartphones, there are 5 billion feature phone users. That's a lot of upside growth potential for BlackBerry and all the other players out there.







Read More..

6 wounded in overnight shootings









Two men were shot in the South Austin neighborhood on the West Side late Wednesday, police said, and four others were wounded across the city.

The 19-year-old and 37-year-old in Austin were in a car in the 5000 block of West Madison Street when someone approached on foot and started shooting, Chicago Police News Affairs Officer Hector Alfaro said.

The pair drove to a “residence” in the 1500 block of North Long Avenue and police were called, Alfaro said. The older man was taken to John H. Stroger Jr. Hospital of Cook County with multiple gunshot wounds and the younger man, shot in the leg, was taken to Loyola University Medical Center.

Nobody is in custody and Area North detectives are investigating.

Also on the West Side, a man in his 30s was shot and found in the 1200 block of South Racine Avenue, outside the Alba-Roberts Brooks Homes housing complex in the University Village / Little Italy neighborhood. It's not clear if he was shot there - police responded to a single call of a person shot and found the man shot in the leg about 2:45 a.m. 

On the Northwest Side about 10:45 p.m., a 56-year-old man was shot in the head in what police first believed to be an attempted suicide. He was shot in the 1800 block of North Natchez Avenue in the Galewood neighborhood, police said. Detectives later determined that someone had shot the man, Chicago Police News Affairs Officer Amina Greer said. He's at Loyola hospital, Greer said. 

A 23-year-old man was shot in the leg and groin in the 3400 block of West Walnut Street just before 8 p.m. in the East Garfield Park neighborhood. He was on a porch when three men, one with a gun, approached and told him and one other person not to move. 

They moved, and one of the three shot the 23-year-old, police said. He was taken to Mount Sinai Hospital and he’s in good condition.

About an hour later, a 43-year-old man was shot by another person inside a silver car in the 8500 block of South Hermitage Avenue in the Gresham neighborhood. He’s in stable condition at Little Company of Mary Hospital.

pnickeas@tribune.comTwitter: @peternickeas 



Read More..

Syrian rebels make slow headway in south


AMMAN (Reuters) - The revolt against President Bashar al-Assad first flared in Deraa, but the southern border city now epitomizes the bloody stalemate gripping Syria after 22 months of violence and 60,000 dead.


Jordan next door has little sympathy with Assad, but is wary of spillover from the upheaval in its bigger neighbor. It has tightened control of its 370-km (230-mile) border with Syria, partly to stop Islamist fighters or weapons from crossing.


That makes things tough for Assad's enemies in the Hawran plain, traditionally one of Syria's most heavily militarized regions, where the army has long been deployed to defend the southern approaches to Damascus from any Israeli threat.


The mostly Sunni Muslim rebels, loosely grouped in tribal and local "brigades", are united by a hatred of Assad and range from secular-minded fighters to al Qaeda-aligned Islamists.


"Nothing comes from Jordan," complained Moaz al-Zubi, an officer in the rebel Free Syrian Army, contacted via Skype from the Jordanian capital Amman. "If every village had weapons, we would not be afraid, but the lack of them is sapping morale."


Insurgents in Syria say weapons occasionally do seep through from Jordan but that they rely more on arsenals they seize from Assad's troops and arms that reach them from distant Turkey.


This month a Syrian pro-government television channel showed footage of what it said was an intercepted shipment of anti-tank weapons in Deraa, without specifying where it had come from.


Assad's troops man dozens of checkpoints in Deraa, a Sunni city that was home to 180,000 people before the uprising there in March 2011. They have imposed a stranglehold which insurgents rarely penetrate, apart from sporadic suicide bombings by Islamist militants, say residents and dissidents.


Rebel activity is minimal west of Deraa, where military bases proliferate near the Israeli-occupied Golan Heights.


Insurgents have captured some towns and villages in a 25-km (17-mile) wedge of territory east of Deraa, but intensifying army shelling and air strikes have reduced many of these to ruin, forcing their residents to join a rapidly expanding refugee exodus to Jordan, which now hosts 320,000 Syrians.


However, despite more than a month of fighting, Assad's forces have failed to winkle rebels out of strongholds in the rugged volcanic terrain that stretches from Busra al-Harir, 37 km (23 miles) northeast of Deraa, to the outskirts of Damascus.


Further east lies Sweida, home to minority Druze who have mostly sat out the Sunni-led revolt against security forces dominated by Assad's minority, Shi'ite-rooted Alawite sect.


"KEY TO DAMASCUS"


As long as Assad's forces control southwestern Syria, with its fertile, rain-fed Hawran plain, his foes will find it hard to make a concerted assault on Damascus, the capital and seat of his power, from suburbs where they already have footholds.


"If this area is liberated, the supply routes from the south to Damascus would be cut," said Abu Hamza, a commander in the rebel Ababeel Hawran Brigade. "Deraa is the key to the capital."


Fighters in the north, where Turkey provides a rear base and at least some supply lines, have fared somewhat better than their counterparts in the south, grabbing control of swathes of territory and seizing half of Aleppo, Syria's biggest city.


They have also captured some towns in the east, across the border from Iraq's Sunni heartland of Anbar province, and in central Syria near the mostly Sunni cities of Homs and Hama.


But even where they gain ground, Assad's mostly Russian-supplied army and air force can still pound rebels from afar, prompting a Saudi prince to call for outsiders to "level the playing field" by providing anti-tank and anti-aircraft weapons.


"What is needed are sophisticated, high-level weapons that can bring down planes, can take out tanks at a distance," Prince Turki al-Faisal, a former intelligence chief and brother of the Saudi foreign minister, said last week at a meeting in Davos.


Saudi Arabia and its fellow Gulf state Qatar have long backed Assad's opponents and advocate arming them, but for now the rebels are still far outgunned by the Syrian military.


"They are not heavily armed, properly trained or equipped," said Ali Shukri, a retired Jordanian general, who argued also that rebels would need extensive training to use Western anti-tank or anti-aircraft weapons effectively even if they had them.


He said two powerful armored divisions were among Syrian forces in the south, where the rebels are "not that strong".


It is easier for insurgents elsewhere in Syria to get support via Turkey or Lebanon than in the south where the only borders are with Israel and Jordan, Shukri said.


Jordan, which has urged Assad to go, but seeks a political solution to the crisis, is unlikely to ramp up support for the rebels, even if its cautious policy risks irritating Saudi Arabia and Qatar, financial donors to the cash-strapped kingdom.


ISLAMIST STRENGTH


"I'm confident the opposition would like to be sourcing arms regularly from the Jordanian border, not least because I guess it would be easier for the Saudis to get stuff up there on the scale you'd be talking about," said a Western diplomat in Amman.


A scarcity of arms and ammunition is the main complaint of the armed opposition, a disparate array of local factions in which Islamist militants, especially the al Qaeda-endorsed Nusra Front, have come to play an increasing role in recent months.


The Nusra Front, better armed than many groups, emerged months after the anti-Assad revolt began in Deraa with peaceful protests that drew a violent response from the security forces.


It has flourished as the conflict has turned ever more bitterly sectarian, pitting majority Sunnis against Alawites.


Since October, the Front, deemed a terrorist group by the United States, has carried out at least three high-profile suicide bombings in Deraa, attacking the officers' club, the governor's residence and an army checkpoint in the city centre.


Such exploits have won prestige for the Islamist group, which has gained a reputation for military prowess, piety and respect for local communities, in contrast to some other rebel outfits tainted by looting and other unpopular behavior.


"So far no misdeeds have come from the Nusra Front to make us fear them," said Daya al-Deen al-Hawrani, a fighter from the rebel al-Omari Brigade. "Their goal and our goal is one."


Abu Ibrahim, a non-Islamist rebel commander operating near Deraa, said the Nusra Front fought better and behaved better than units active under the banner of the Free Syrian Army.


"Their influence has grown," he acknowledged, describing them as dedicated and disciplined. Nor were their fighters imposing their austere Islamic ideology on others, at least for now. "I sit with them and smoke and they don't mind," he said.


The Nusra Front may be trying to avoid the mistakes made by a kindred group, Al Qaeda in Iraq, which fought U.S. troops and the rise of Shi'ite factions empowered by the 2003 invasion.


The Iraqi group's suicide attacks on civilians, hostage beheadings and attempts to enforce a harsh version of Islamic law eventually alienated fellow Sunni tribesmen who switched sides and joined U.S. forces in combating the militants.


Despite the Nusra Front's growing prominence and its occasional spectacular suicide bombings in Deraa, there are few signs that its fighters or other rebels are on the verge of dislodging the Syrian military from its southern bastions.


Abu Hamza, the commander in the Ababeel Hawran Brigade, was among many rebels and opposition figures to lament the toughness of the task facing Assad's enemies in the south: "What is killing us is that all of Hawran is a military area," he said.


"And every village has five army compounds around it."


(Writing by Alistair Lyon; Editing by Alastair Macdonald)



Read More..

Stock futures flat ahead of data; Amazon, Boeing climb early


NEW YORK (Reuters) - Stock index futures were flat on Wednesday as investors digested recent gains and awaited key U.S. economic data, though Amazon and Boeing both rose after earnings topped expectations.


Equities have soared in recent weeks, with the S&P 500 rising for nine of the past 10 sessions. The Dow Jones industrial average has been flirting with 14,000, a level it hasn't seen since October 2007. Many analysts have said markets may need to take a pause at current levels.


The first read on U.S. fourth-quarter economic growth is due at 8:30 a.m. Analysts see a 1.1 percent annualized pace of growth in GDP, down from the 3.1 percent in the third quarter.


"I wouldn't read too much into the slowing from the third quarter, since that was impacted by (superstorm) Sandy and the fiscal cliff. The momentum in the data has been strong, which could be enough to keep us grinding higher," said John Brady, managing director at R.J. O'Brien & Associates in Chicago.


Traders will also look to the January ADP employment report, which is expected to show 165,000 private-sector jobs were created in the month, down from 215,000 in December. The report precedes the closely watched nonfarm payroll report on Friday, which is expected to show modest but steady job growth.


Amazon.com Inc was the latest high-profile name to rally after results, rising 8.8 percent to $283.30 in premarket trading a day after the online retailer reported better-than-expected fourth-quarter earnings and strong revenue growth. The rally put the stock within striking distance of an all-time high.


Boeing Co rose 1 percent to $74.35 before the bell after reporting adjusted fourth-quarter earnings that beat expectations. The Dow component also said that while production continued on its Dreamliner segment, which has had technical problems recently, it was suspending delivery until clearance was granted by the Federal Aviation Administration.


Thomson Reuters data showed that of the 174 companies in the S&P 500 that have reported earnings this season, 68.4 percent have been above analyst expectations, which is a higher proportion than over the past four quarters and above the average since 1994.


S&P 500 futures fell 0.7 point but remained above fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures were flat and Nasdaq 100 futures rose 2 points.


The S&P has been hovering around 1,500, a level market technicians say is an inflection point that will determine the overall direction in the near term. The benchmark index is on track to post its best monthly performance since October 2011 as investors poured $55 billion in new cash into stock mutual funds and exchange-traded funds in January, the biggest monthly inflow on record.


The Federal Reserve concludes a two-day meeting on Wednesday, and while the central bank is expected to keep monetary policy on a steady path, intensive debates continue behind the scenes over when the controversial bond-buying program should be curtailed.


In company news, Chesapeake Energy Corp rose 10.5 percent to $20.95 in premarket trading a day after saying Aubrey McClendon would step down as chief executive after a year in which a series of Reuters investigations triggered civil and criminal probes of the second-largest U.S. natural gas producer.


U.S. stocks advanced on Tuesday, led by defensive sectors, in a sign the cash piles recently moving into the market are being put to use by cautious investors to pick up more gains.


(Editing by Chizu Nomiyama)



Read More..

A-Rod implicated in PED use again as MLB probes


NEW YORK (AP) — Alex Rodriguez is in the middle of Major League Baseball's latest doping investigation after an alternative weekly newspaper reported baseball's highest-paid star was among the big leaguers listed in the records of a Florida clinic the paper said sold performance-enhancing drugs.


The Miami New Times said Tuesday that the three-time AL MVP bought human growth hormone and other performance-enhancing substances during 2009-12 from Biogenesis of America LLC, a now-closed anti-aging clinic in Coral Gables, Fla., near Rodriguez's offseason home.


The new public relations firm for the New York Yankees third baseman issued a statement denying the allegations.


New Times said it obtained records detailing purchases by Rodriguez, 2012 All-Star game MVP Melky Cabrera, 2005 AL Cy Young Award winner Bartolo Colon and 2011 AL championship series MVP Nelson Cruz of Texas.


Cabrera left San Francisco after the season to sign with Toronto, while Oakland re-signed Colon.


Other baseball players the newspaper said appeared in the records include Washington pitcher Gio Gonzalez, who finished third in last year's NL Cy Young Award voting, and San Diego catcher Yasmani Grandal.


Biogenesis, which the New Times said was run by Anthony Bosch, was located in a beige, nondescript office park. The former clinic is no longer listed as a business in its directory,


"There was a flier put out by the building management a couple weeks ago. It was put on all the doors and windows of all the offices," said Brad Nickel, who works in a cruise planning company on the floor above where the clinic was located. "It just said this guy's not really a doctor, he doesn't belong here, he's no longer allowed here, call the police or the building management if you see him."


The New Times posted copies of what it said were Bosch's handwritten records, obtained through a former Biogenesis employee it did not identify.


Bosch's lawyer, Susy Ribero-Ayala, said in a statement the New Times report "is filled with inaccuracies, innuendo and misstatements of fact."


"Mr. Bosch vehemently denies the assertions that MLB players such as Alex Rodriguez and Gio Gonzalez were treated by or associated with him," she said.


Rodriguez appears 16 times in the documents New Times received, the paper said, either as "Alex Rodriguez," ''Alex Rod" or the nickname "Cacique," a pre-Columbian Caribbean chief.


Rodriguez admitted four years ago that he used PEDs from 2001-03. Cabrera, Colon and Grandal were suspended for 50 games each last year by MLB following tests for elevated testosterone. Responding to the testosterone use, MLB and the players' union said Jan. 10 they were authorizing the World Anti-Doping Agency laboratory outside Montreal to store each major leaguer's baseline testosterone/epitestosterone (T/E) ratio in order to detect abnormalities.


"We are always extremely disappointed to learn of potential links between players and the use of performance-enhancing substances," MLB said in a statement. "Only law enforcement officials have the capacity to reach those outside the game who are involved in the distribution of illegal performance-enhancing drugs. ... We are in the midst of an active investigation and are gathering and reviewing information."


A baseball official, speaking on condition of anonymity because he was not authorized to make public statements, said Monday that MLB did not have any documentation regarding the allegations. If MLB does obtain evidence, the players could be subject to discipline. First offenses result in a 50-game suspension and second infractions in 100-game penalties. A third violation results in a lifetime ban.


Rodriguez is sidelined for at least the first half of the season after hip surgery Jan. 16. A 50-game suspension would cost him $7.65 million of his $28 million salary.


"The news report about a purported relationship between Alex Rodriguez and Anthony Bosch are not true," Rodriguez said in a statement issued by a publicist. "He was not Mr. Bosch's patient, he was never treated by him and he was never advised by him. The purported documents referenced in the story — at least as they relate to Alex Rodriguez — are not legitimate."


Jay Reisinger, a lawyer who has represented Rodriguez in recent years, said the three-time AL MVP had retained Roy Black, an attorney from Rodriguez's hometown of Miami. Black's clients have included Rush Limbaugh and William Kennedy Smith.


Bosch did not return a phone message seeking comment.


MLB hopes to gain the cooperation of Bosch and others connected with the clinic, another baseball official said, also on condition of anonymity because no public statements on the matter were authorized. In order to successfully discipline players based on the records, witnesses would be needed to authenticate them, the official said.


Players could be asked to appear before MLB for interviews, but the official said MLB would be reluctant to request interviews before it has more evidence.


Rodriguez spent years denying he used PEDs before Sports Illustrated reported in February 2009 that he tested positive for two steroids in MLB's anonymous survey while with the Texas Rangers in 2003. Two days later, he admitted in an ESPN interview that he used PEDs over a three-year period. He has denied using PEDs after 2003.


If the new allegations were true, the Yankees would face high hurdles to get out of the final five years and $114 million of Rodriguez's record $275 million, 10-year contract. Because management and the players' union have a joint drug agreement, an arbitrator could determine that any action taken by the team amounted to multiple punishments for the same offense.


But if Rodriguez were to end his career because of the injury, about 85 percent of the money owed by the Yankees would be covered by insurance, one of the baseball officials said.


Gonzalez, 21-8 for the Washington Nationals last season, posted on his Twitter feed: "I've never used performance enhancing drugs of any kind and I never will, I've never met or spoken with tony Bosch or used any substance provided by him. anything said to the contrary is a lie."


Colon was not issuing a statement, agent Adam Katz said through spokeswoman Lisa Cohen.


"We are aware of certain allegations and inferences," Cruz's law firm, Farrell & Reisinger, said in a statement. "To the extent these allegations and inferences refer to Nelson, they are denied."


Cruz and Gonzalez had not previously been linked to performance-enhancing drugs. Cruz hit 24 home runs last year for the Rangers.


The New Times report said it obtained notes by Bosch listing the players' names and the substances they received. Several unidentified employees and clients confirmed to the publication that the clinic distributed the substances, the paper said. The employees said that Bosch bragged of supplying drugs to professional athletes but that they never saw the sports stars in the office.


The paper said the records list that Rodriguez paid for HGH; testosterone cream; IGF-1, a substance banned by baseball that stimulates insulin production; and GHRP, which releases growth hormones.


___


Associated Press writers Jennifer Kay in Coral Gables, Fla., and Curt Anderson in Miami, and AP Sports Writers Howard Fendrich and Tim Reynolds contributed to this report.


Read More..